Enanta Pharmaceuticals Inc (ENTA)
R&D Expense Growth
-18.81%
Fiscal year · Period ending:
ENTA R&D Expense Growth
Latest reported-18.81%period ending
Latest reported-18.81%period ending
ENTA FY R&D Growth (YoY) (0.00% → -18.81%)
Latest values, visible window
High-resolution chart · PNG
ENTA r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -18.8141% | |
| -19.5983% | |
| -0.6066% | |
| -5.5074% | |
| 27.3151% | |
| -3.8372% | |
| 49.9251% | |
| 65.1077% | |
| 41.9911% | |
| 74.4836% | |
| 23.7407% | |
| 11.2761% | |
| 11.4191% | |
| 30.8998% | |
| 18.8452% | |
| 0% |